Effects of angiotensin II receptor blockers on relationships between 24-hour blood pressure, autonomic function, and health-related QOL

Clinical and Experimental Hypertension

Volumn 31, Issue 3, 2009, Pages 250-258

  Okano, Yasuko ^a   Tamura, Kouichi ^a   Kuji, Tadashi ^a   Masuda, Shinitirou ^a   Tochikubo, Osamu ^b   Umemura, Satoshi ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

24 h blood pressure; Angiotensin II receptor blocker; Autonomic function; SF 36

Indexed keywords

ALBUMIN; CANDESARTAN; CREATININE; LOSARTAN; OLMESARTAN; POTASSIUM; TELMISARTAN; VALSARTAN; ANGIOTENSIN RECEPTOR ANTAGONIST; BENZIMIDAZOLE DERIVATIVE; BENZOIC ACID DERIVATIVE; DRUG DERIVATIVE; IMIDAZOLE DERIVATIVE; TETRAZOLE DERIVATIVE; VALINE;

ADRENERGIC SYSTEM; ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE MONITORING; CHOLINERGIC SYSTEM; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG EFFECT; DRUG MECHANISM; FEMALE; HEART RATE VARIABILITY; HUMAN; HYPERTENSION; JAPANESE; MALE; POTASSIUM BLOOD LEVEL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SHORT FORM 36; UREA NITROGEN BLOOD LEVEL; BLOOD PRESSURE; CIRCADIAN RHYTHM; DOSE RESPONSE; HEALTH SURVEY; HEART RATE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT;

AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; AUTONOMIC NERVOUS SYSTEM; BENZIMIDAZOLES; BENZOATES; BLOOD PRESSURE; CIRCADIAN RHYTHM; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEALTH SURVEYS; HEART RATE; HUMANS; HYPERTENSION; IMIDAZOLES; LOSARTAN; MALE; MIDDLE AGED; QUALITY OF LIFE; TETRAZOLES; VALINE;

EID: 67649975949     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.1080/10641960902822500     Document Type: Article

References (30)

1. Dahlöf B, Lindholm LH, Carney S, Pentikäinen PJ, Östergren J. Main results of the losartan versusamlodipine (LOA) study on drug tolerability and psychological general well-being. J Hypertens. 1997;15:1327-1335.
2. Oparil S, Barr E, Elkins M, Liss C, Vrecenak A, Edelman J. Efficacy, tolerability and effects on quality of life of losartan, alone or with hydrochlothiazide versus amlodipine inpatients with essential hypertension. Clin Therapeutics 1996;18:608-625.
3. Yamamoto S, Kawashima T, Kunitake T, Koide S, Fujimoto H. Symptom assessment and quality of life in hypertensive patients following modification of antihypertensive therapy to a regimen containing valsartan. J Clin Outcome Res. 2004;8:1-14.
4. Thaker D, Frech F, Gil M. Adverse event reporting of ACEI and ARB associated angioedema. Am J Hypertens. 2005;18:A116.
5. Mancia G, Zanchetti A, Agebiti-Rosei E, Benemio G, Cesaris RD, Fogari R, Pessino A, Porcellati C, Salvetti A, Trimarco B. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. Circulation 1997;95:1464-1470.
6. Fagard RH, Staessen JA, Thijs L. Relationships between changes in left ventricular mass and in clinic and ambulatory blood pressure in response to antihypertensive therapy. J Hypertens. 1997;15 (part 1):1493-1502.
7. Khattar RS, Senior R, Lahiri A. Cardiovascular outcome in white-coat versus sustained mild hypertension: A 10-year follow-up study. Circulation 1998;98:1892-1897.
8. Tochikubo O, Ikeda A, Miyajima E, Ishii M. Effects of insufficient sleep on blood pressure monitored by a new multi-biomedical recorder. Hypertension 1996;27:1318-1324.
9. Somers VK, Dyken ME, Mark AL, Abbound FM. Sympathetic nerve activity during sleep in normal subjects. N Engl J Med. 1993;328:303-307.
10. Tarlov AR, Ware JE, Greenfield S, Nelson EC, Perrin E, Zubkoff M. The medical outcome study: an application of methods for monitoring the results of medical care. JAMA 1989;262:925-930.
11. Ware JE, Kosinki M, Keller SD. SF-36 Physical and Mental Health Summary Scales: A User's Manual. Boston, MA: Health Institute, 1994.
12. Okano Y, Tochikubo O, Umemura S. Relationship between base blood pressure during sleep and health-related quality of life in healthy adults. J Hum Hypertens. 2007;21:135-140.
13. World Health Organization. Arterial hypertension: Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 1978;628:7-56.
14. Clark S, Fowler S, Coats A, Radaelli A, van der Putt M, Bird R, Conway J. Ambulatory blood pressure monitoring: Validation of the accuracy and reliability of the TM2420 according to the AAMI recommendations. J Hum Hypertens. 1991; 5:77-82.
15. Pomeranz B, Macaulay RJB, Caudill MA, Kutz I, Adam D, Gordon D, Kilborn KM, Barger AC, Shannon DC, Cohen RJ, Benson H. Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol. 1985;248:H151-H153.
16. Fukuhara S, Bito S, Green J, Hsiao A, Kurokawa K. Translation, adaptation, and validation of the SF-36 health survey for use in Japan. J Clin Epidemiol. 1998;11:1037-1044.
17. Fukuhara S, Ware JE, Kosinski M, Wada S, Gandek B. Psychometric and clinical tests of validity of the Japanese SF-36 health survey. J Clin Epidemiol. 1998;11:1045-1053.
18. Furberg C, Psaty B. Corrections to the nifedipine metaanalysis. Circulation 1996;93:1475-1476.
19. Furberg C, Psaty B, Meyer J. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation 1995;92:1326-1331.
20. Baumgart P, Walger P, Fuchs G, Dorst KG, Vetter H, Rahn KH. Twenty-four hour blood pressure is not dependent on endogenous circadian rhythm. J Hypertens 1989;7:331-334.
21. Munakata M, Nagasaki A, Nunokawa T, Sakuma T, Kato H, Yoshinaga K, Toyota T. Effects of valsartan and Nifedipine coat-core on systemic arterial stiffness in hypertensive patients. Am J Hypertens. 2004;17:1050-1055.
22. Kakinoki S, Nomura A, Takechi S, Kitabatake A. Effects of short-and long-acting calcium channel blockers on the relationship between blood pressure and physical activity. Am J Hypertens. 2001;14:66-69.
23. Mahmud A, Feely J. Reduction in arterial stiffness with angiotensin II antagonist is comparable with and additive to ACE inhibition. Am J Hypertens. 2002;15:321-325.
24. Wolk R, Kulakowski P, Ceremuzynski L. Nifedipine and captopril exert divergent effects on heart rate variability in patients with acute episodes of hypertension. J Hum Hypertens. 1996;10:327-332.
25. Klein I, Ligtenberg G, Oey PL, Koomans HA, Blankestijn PJ. Enalapril and Losartan reduce sympathetic hyperactivity in patients with chronic renal failure. J Am Soc Nephrol. 2003;14:425-430.
26. Schwartz GL, Bailey KR, Mosley T, Knopman DS, Jack CR, Canzanello V, Turner ST. Association of ambulatory blood pressure with ischemic brain injury. Hypertension 2007; 49:1228-1234.
27. Julius S, Nesbitt S. Sympathetic overactivity in hypertension: a moving target. Am J Hypertens. 1996;9:113s-120s.
28. Sakata K, Kumagai H, Osaka M, Onami T, Matsuura T, Imai M, Saruta T. Potentiated sympathetic nervous and rennin-angiotensin systems reduce nonlinear correlation between sympathetic activity and blood pressure in conscious spontaneously hypertensive rats. Circulation 2002;106:620-625.
29. Krum H, Lambert E, Windebank E, Campbell DJ, Esler M. Effect of angiotensin II receptor blockade on autonomic nervous system function in patients with essential hypertension. Am J Physiol Heart Circ Physiol. 2006;290:H1706-1712.
30. See S, Stirling AL. Candesartan cilexetil: an angiotensin II-recepter blocker. Am J Health Syst Pharm. 2000;57:739-746.